| Nuha Krad, MD | |
|
3800 Reservoir Rd Nw, Washington, DC 20007-2113 | |
| (708) 829-3549 | |
| Not Available |
| Full Name | Nuha Krad |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 16 Years |
| Location | 3800 Reservoir Rd Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821258849 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | MD041245 (District Of Columbia) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 036134465 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mountain View Regional Medical Center | Las cruces, NM | Hospital |
| Memorial Medical Center | Las cruces, NM | Hospital |
| Havasu Regional Medical Center | Lake havasu city, AZ | Hospital |
| Carlsbad Medical Center | Carlsbad, NM | Hospital |
| Paris Regional Medical Center | Paris, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Golden State Imaging Associates Inc | 1254761315 | 230 |
| Sonoran Radiology Ltd | 3375964505 | 367 |
| Imaging Associates Of New Mexico Llc | 4981970233 | 97 |
| Singleton Associates Pa | 6305731118 | 691 |
| Eagle Partners Pllc | 9032205752 | 92 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Coastal Radiology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144270307 PECOS PAC ID: 8224002696 Enrollment ID: O20120801000809 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Eagle Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548450976 PECOS PAC ID: 9032205752 Enrollment ID: O20140317001788 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20150701002707 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Imaging Associates Of New Mexico Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629592464 PECOS PAC ID: 4981970233 Enrollment ID: O20180220001048 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Sierra Vista Hospital 69 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760446009 PECOS PAC ID: 0143122416 Enrollment ID: O20191023002871 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Greensboro Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821035999 PECOS PAC ID: 8729074901 Enrollment ID: O20200227002497 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Golden State Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144872052 PECOS PAC ID: 1254761315 Enrollment ID: O20200414001788 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Entity Name | Sonoran Radiology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033745708 PECOS PAC ID: 3375964505 Enrollment ID: O20200701001467 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nuha Krad, MD 3800 Reservoir Rd Nw, Washington, DC 20007-2113 Ph: (708) 829-3549 | Nuha Krad, MD 3800 Reservoir Rd Nw, Washington, DC 20007-2113 Ph: (708) 829-3549 |
News Archive
In an opinion piece in The Hill's "Congress Blog," Taufiqur Rahman, an international health consultant and founder of the Center for Implementation Efficiency, explores the concept of "venture social investment or VSI," in which the idea of venture capitalism is used "to reward good ideas or sustainable initiatives by investing limited foreign aid money to gain a much bigger and sustainable impact in developing countries" and creating "a partnership between developed world and low-income countries."
Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Mayo Clinic researchers are sharing their latest research findings this week at the American Academy of Child and Adolescent Psychiatry Meeting in Toronto.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.
› Verified 6 days ago
Kimberly Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-902-1073 | |
Dr. Michael B Shvarts, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Joel Bowers, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 | |
Krista Lyn Mcfarren, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite 102, Washington, DC 20016 Phone: 202-966-0606 Fax: 202-244-6757 | |
Ranjith Vellody, MD Radiology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Aaron Conard, Radiology Medicare: Not Enrolled in Medicare Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 240-366-7325 | |
Dr. Estelle Cooke-sampson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 6101, Washington, DC 20060 Phone: 202-865-6679 Fax: 202-865-3138 |